These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21191044)

  • 1. Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking.
    Wolf C; Rosefort C; Fallah G; Kassack MU; Hamacher A; Bodnar M; Wang H; Illes P; Kless A; Bahrenberg G; Schmalzing G; Hausmann R
    Mol Pharmacol; 2011 Apr; 79(4):649-61. PubMed ID: 21191044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt bridge switching from Arg290/Glu167 to Arg290/ATP promotes the closed-to-open transition of the P2X2 receptor.
    Hausmann R; Günther J; Kless A; Kuhlmann D; Kassack MU; Bahrenberg G; Markwardt F; Schmalzing G
    Mol Pharmacol; 2013 Jan; 83(1):73-84. PubMed ID: 23041661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
    Hausmann R; Schmalzing G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
    Hausmann R; Rettinger J; Gerevich Z; Meis S; Kassack MU; Illes P; Lambrecht G; Schmalzing G
    Mol Pharmacol; 2006 Jun; 69(6):2058-67. PubMed ID: 16551782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
    Meis S; Hamacher A; Hongwiset D; Marzian C; Wiese M; Eckstein N; Royer HD; Communi D; Boeynaems JM; Hausmann R; Schmalzing G; Kassack MU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):238-47. PubMed ID: 19815812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Suzuki E; Kessler M; Montgomery K; Arai AC
    Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thr339-to-serine substitution in rat P2X2 receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys308.
    Cao L; Young MT; Broomhead HE; Fountain SJ; North RA
    J Neurosci; 2007 Nov; 27(47):12916-23. PubMed ID: 18032665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X3 and P2X2/3 receptor antagonists.
    Bölcskei H; Farkas B
    Pharm Pat Anal; 2014 Jan; 3(1):53-64. PubMed ID: 24354979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
    El-Ajouz S; Ray D; Allsopp RC; Evans RJ
    Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antagonist-insensitive P2X receptor expressed in epithelia and brain.
    Buell G; Lewis C; Collo G; North RA; Surprenant A
    EMBO J; 1996 Jan; 15(1):55-62. PubMed ID: 8598206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High potency zinc modulation of human P2X2 receptors and low potency zinc modulation of rat P2X2 receptors share a common molecular mechanism.
    Punthambaker S; Blum JA; Hume RI
    J Biol Chem; 2012 Jun; 287(26):22099-111. PubMed ID: 22556417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
    Farmer LK; Schmid R; Evans RJ
    J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.
    Trujillo CA; Majumder P; Gonzalez FA; Moaddel R; Ulrich H
    J Pharm Biomed Anal; 2007 Jul; 44(3):701-10. PubMed ID: 17481842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin analogues as subtype-selective G protein inhibitors.
    Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
    Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory purinergic transmission in mouse caecum: role for P2Y1 receptors as prejunctional modulators of ATP release.
    Zizzo MG; Mulè F; Serio R
    Neuroscience; 2007 Dec; 150(3):658-64. PubMed ID: 17997228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structual and functional dynamics of the ATP receptor channel P2X(2)].
    Kubo Y; Fujiwara Y; Keceli B; Nakajo K
    Brain Nerve; 2010 Dec; 62(12):1323-9. PubMed ID: 21139185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent.
    Davies DL; Machu TK; Guo Y; Alkana RL
    Alcohol Clin Exp Res; 2002 Jun; 26(6):773-8. PubMed ID: 12068244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct gating of ATP-activated ion channels (P2X2 receptors) by lipophilic attachment at the outer end of the second transmembrane domain.
    Rothwell SW; Stansfeld PJ; Bragg L; Verkhratsky A; North RA
    J Biol Chem; 2014 Jan; 289(2):618-26. PubMed ID: 24273165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.